Global Patent Index - EP 1254150 A2

EP 1254150 A2 2002-11-06 - NUCLEIC ACIDS, PROTEINS, AND ANTIBODIES

Title (en)

NUCLEIC ACIDS, PROTEINS, AND ANTIBODIES

Title (de)

NUKLEINSÄUREN, PROTEINE UND ANTIKÖRPER

Title (fr)

ACIDES NUCLEIQUES, PROTEINES ET ANTICORPS

Publication

EP 1254150 A2 (EN)

Application

EP 01914332 A

Priority

  • US 0101360 W
  • US 17906500 P
  • US 18062800 P
  • US 20946700 P
  • US 23239800 P
  • US 24930000 P
  • US 25016000 P
  • US 25199000 P
  • US 25186800 P

Abstract (en)

[origin: WO0155329A2] The present invention relates to novel ovarian related polynucleotides and the polypeptides encoded by these polynucleotides herein collectively known as "ovarian antigens", and the use of such ovarian antigens for detecting disorders of the ovaries and/or breast, particularly the presence of ovarian and/or breast cancer and ovarian and/or breast cancer metastases. More specifically, isolated ovarian associated nucleic acid molecules are provided encoding novel ovarian associated polypeptides. Novel ovarian polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for producing human ovarian associated polynucleotides and/or polypeptides. The invention further relates to diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to the ovaries and/or breast, including ovarian and/or breast cancer, and therapeutic methods for treating such disorders. The invention further relates to screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further relates to methods and/or compositions for inhibiting the production and function of the polypeptides of the present invention.

IPC 1-7 (main, further and additional classification)

C07H 21/02; C07H 21/04; C07K 5/00; C12N 1/20; C12N 5/00; C12N 15/63; C12P 21/06; C12Q 1/68

IPC 8 full level (invention and additional information)

C07H 21/02 (2006.01); C07H 21/04 (2006.01); C07K 5/00 (2006.01); C07K 14/00 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C12N 1/20 (2006.01); C12N 5/00 (2006.01); C12N 15/12 (2006.01); C12N 15/63 (2006.01); C12P 21/06 (2006.01); C12Q 1/68 (2006.01)

IPC 8 main group level (invention and additional information)

C12N (2006.01)

CPC (invention and additional information)

C07H 21/02 (2013.01); C07H 21/04 (2013.01); C07K 5/00 (2013.01); C07K 14/00 (2013.01); C07K 14/47 (2013.01); C07K 16/18 (2013.01); C12N 1/00 (2013.01); C12N 1/20 (2013.01); C12N 5/00 (2013.01); C12N 15/63 (2013.01); C12P 21/06 (2013.01); C12Q 1/68 (2013.01)

Citation (search report)

See references of WO 0155329A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

EPO simple patent family

WO 0155329 A2 20010802; WO 0155329 A3 20020207; WO 0155329 A8 20010907; AU 3972801 A 20010807; CA 2393954 A1 20010802; EP 1254150 A2 20021106

INPADOC legal status


2003-01-29 [18W] APPLICATION WITHDRAWN

- Effective date: 20021126

2002-11-06 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20020828

2002-11-06 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

2002-11-06 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO:

- Free text: AL;LT;LV;MK;RO;SI